您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Miao Zhu1, Qin Xiao2, Xinzhen Cai3
1Department of Hematology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China; The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou University, Yangzhou 225001, China; Yangzhou Hematology Laboratory, Yangzhou 225001, China.
乳化,一种新的修饰,影响淋巴瘤预后和药物反应. 一种新的乳化风险评分模型有助于分层患者,并指导扩散大B细胞淋巴瘤的治疗选择.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: